1.07 USD
↘ 0.01 (0.93%)AT CLOSE (03:59 PM EDT)
Talphera, Inc. Common Stock
TLPHNASDAQ • USD
1.07
↘ 0.01 (0.47%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.07
↘ 0.01 (0.47%)
Market: CLOSED
Talphera, Inc. Common Stock (TLPH) is currently trading at $1.07. The technical outlook is "Neutral" and the fundamental picture shows "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TLPH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.06
High?$1.08
Low?$1.05
Prev. Close?$1.08
Volume?42.4K
Avg. Volume?121.0K
VWAP?$1.06
Rel. Volume?0.35x
Bid / Ask
Bid?$1.04 × 500
Ask?$1.07 × 300
Spread?$0.03
Midpoint?$1.06
Valuation & Ratios
Market Cap?55.5M
Shares Out?51.9M
Float?26.0M
Float %?50.1%
P/E Ratio?N/A
P/B Ratio?3.86
EPS?-$0.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Employees
12
Market Cap
56.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2011-02-11
Address
1850 GATEWAY DRIVE
SAN MATEO, CA 94404
Phone: 650-216-3500
SAN MATEO, CA 94404
Phone: 650-216-3500
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?33
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.76Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?4.10%Low
Short Interest?1.1M
Days to Cover?6.3
Free Float26.0M
Avg Daily Volume170.5K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.79Adequate
Quick Ratio?1.79Adequate
Cash Ratio?0.07Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.86FAIR▾
Peers100
S&P46
P/S?55,539.20HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
S&P97
EV/Sales?54,797.20HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-104.7%WEAK▾
S&P3
ROA?-56.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12270000
Enterprise Value?$54.8M
Fundamentals ratios updated end of day